TITLE

Forum

PUB. DATE
April 2009
SOURCE
Pharmaceutical Medicine - New Zealand;2009, Vol. 23 Issue 2, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article covers issues related to the pharmaceutical sector as of April 2009. Margaret Chan, World Health Organization (WHO) director-general, has noted in a statement that the global economic crisis is affecting world health. U.S. National Institute of Health (NIH) Raynard Kington has suggested that studies on the cost effectiveness of medical treatments be covered under the economic stimulus package. The initiative Safety of Key Inhaled and Intravenous Drugs in Pediatrics (SAFEKIDS) has been launched by the U.S. Food and Drug Administration.
ACCESSION #
43545706

 

Related Articles

  • Funding of cost-effectiveness studies could cause controversy.  // PharmacoEconomics & Outcomes News;4/18/2009, Issue 576, p2 

    The article focuses on the suggestion of Raynard Kington, acting director of the U.S. National Institute of Health (NIH), to finance studies on the cost effectiveness of medical treatments under the American Recovery and Reinvestment Act (ARRA). Kington proposed a $10.4 billion allocation for...

  • Pitch Perfect. Johnston, Josephine // Scientist;Jan2012, Vol. 26 Issue 1, p24 

    The article focuses on the issue of academic detailing related to the pharmaceutical industry in the U.S. It highlights the American Recovery and Reinvestment Act, which directed funds amounting 150 billion dollars to health care. It states that comparative effectiveness research is different...

  • Building an ELECTRONIC RECORD BRIDGE. Comer, Benjamin // Pharmaceutical Representative;Sep2011, Vol. 41 Issue 9, p22 

    The article reports on the creation of electronic health records (EHRs) in the pharmaceutical industry. It discusses the 19.2 billion U.S. dollars earmarked by the administration of U.S. President Barack Obama for EHRs as part of the American Recovery and Reinvestment Act (ARRA). Moreover, a...

  • Stimulus Bill Dedicates $1.1B to Comparing Treatment Options. Chambers, Heather // San Diego Business Journal;7/20/2009, Vol. 30 Issue 29, p23 

    The article reports on the allocation of 1.1 billion U.S. dollars for the so-called comparative effectiveness research to compare treatment options in the economic stimulus package in the U.S. According to proponents, head-to-head studies comparing one treatment over another has potential for...

  • Possible Outcomes of Comparative Effectiveness Research. Brook, Robert H. // JAMA: Journal of the American Medical Association;7/8/2009, Vol. 302 Issue 2, p194 

    The author comments on the cost effect of spending $1 billion on comparative effectiveness research in the U.S. under the American Recovery and Reinvestment Act. He says discussions indicate that most of the funds will be spent comparing one clinical procedure, device or drug with another. He...

  • FDA snubbed in stimulus. von Eschenbach, Andrew C.; Oliver, Wayne W. // Hill;10/8/2009, Vol. 16 Issue 115, p28 

    The author presents his views on on the omission of the U.S. Food and Drug Administration (FDA) from the 2009 economic stimulus package.

  • GOVERNMENT.  // Business Journal Serving Fresno & the Central San Joaquin Valley;2/19/2010, Issue 324143, p6 

    The article reports that Farmersville and Woodlake towns in Tulare County, California will receive stimulus funds from the U.S. American Recovery and Reinvestment Act.

  • Tulare projects awarded Act funds Recovery.  // Business Journal Serving Fresno & the Central San Joaquin Valley;6/4/2010, Issue 324187, p4 

    The article reports that the projects in Tulare County, California including the Ivanhoe Boys & Girls Club and Tulare Local Health Care District will be funded by the American Recovery and Reinvestment Act.

  • Stimulus is expanding small-biz lending. Wojtowicz, Jean // Indianapolis Business Journal;7/27/2009, Vol. 30 Issue 21, p24A 

    The article provides an answer to the question on the aid of the economic stimulus package on small business in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics